Viridian Therapeutics, Inc.\DE (VRDN) Times Interest Earned: 2014-2025
Historic Times Interest Earned for Viridian Therapeutics, Inc.\DE (VRDN) over the last 11 years, with Sep 2025 value amounting to -$71.45.
- Viridian Therapeutics, Inc.\DE's Times Interest Earned rose 54.72% to -$71.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$108.43, marking a year-over-year decrease of 0.72%. This contributed to the annual value of -$98.17 for FY2024, which is 28.74% up from last year.
- As of Q3 2025, Viridian Therapeutics, Inc.\DE's Times Interest Earned stood at -$71.45, which was up 65.60% from -$207.72 recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Times Interest Earned ranged from a high of -$64.04 in Q4 2024 and a low of -$9,694 during Q4 2021.
- Its 3-year average for Times Interest Earned is -$167.00, with a median of -$120.92 in 2024.
- In the last 5 years, Viridian Therapeutics, Inc.\DE's Times Interest Earned crashed by 1,825.94% in 2021 and then skyrocketed by 96.99% in 2022.
- Viridian Therapeutics, Inc.\DE's Times Interest Earned (Quarterly) stood at -$9,694 in 2021, then spiked by 96.99% to -$292.06 in 2022, then surged by 73.28% to -$78.03 in 2023, then rose by 17.94% to -$64.04 in 2024, then skyrocketed by 54.72% to -$71.45 in 2025.
- Its Times Interest Earned was -$71.45 in Q3 2025, compared to -$207.72 in Q2 2025 and -$160.18 in Q1 2025.